Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
07/1999
07/13/1999US5922350 Dehydration in presence of sugars present at a protectiveconcentration on both inside and outside surfaces; liposomeshave ion concentration gradient capable of generatingtransmember potential to load charged material
07/13/1999US5922349 Dispensing non-discrete doses of estrogen and progestogen concurrently onto delivery surface and transferring dispensed doses to site of administration, repeating the procedure on predetermined schedule, periodically varying dosage
07/13/1999US5922347 Low water content, separated spatially form basic component;rapid absorption; good tolerance in mouth; high bioavailabiltiy; storage stability
07/13/1999US5922346 A mixtures of reduced glutathione, selenium or a selenium compound for reducing free radical damage induced by tobacco products and environmental pollutants
07/13/1999US5922342 Lateral edge coated controlled release pharmaceutical compositions
07/13/1999US5922341 Administering an antidepressant, antiserotonin agent or adrenergic blocking agent
07/13/1999US5922340 Administering with glucocorticoid; sustained release
07/13/1999US5922338 Polyol esters, their preparation and use in depot forms of pharmacologically active agents
07/13/1999US5922323 Transferrin receptor genes and immunogenic compositions derived therefrom
07/13/1999US5922314 Skin preparation composition
07/13/1999US5922313 Lotion consists of a mixture of polyvinylpyrrolidone and hydroxyethyl cellulose, an antibacterial agent chlorhexidine digluconate or 2,4,4'-trichloro-2'-hydroxydiphenylether, blend of glyceryl stearate and polyethylene glycol emulsifer
07/13/1999US5922311 Oil-in-water emulsion, compositions comprising an oil-in-water emulsion, and uses thereof
07/13/1999US5922306 Inhalants dispersion comprising tetrafluoroethane/1,1,1,2-/ propellant, drug particles precoated with surfactant, the drug formulation consists of betamethasone, ergotamine tartrate or sodium cromoglycate for respiratory system disorders
07/13/1999US5922305 Methods of treating tissues with oxygen-supersaturated emulsions
07/13/1999US5922304 Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
07/13/1999US5922253 Production scale method of forming microparticles
07/13/1999US5922209 Applying an electric charge to bacteria or virus which exceeds the electrostatic capacity of the cell, promotes osmosis
07/13/1999CA2259098A1 Sustained-release pharmaceutical composition
07/13/1999CA2257547A1 Process for producing solid dosage forms
07/13/1999CA2256836A1 Lip care composition containing acexamic acid, its uses
07/13/1999CA2159985C Methods of using hesperetin for sebum control and treatment of acne
07/13/1999CA2157793C Macromolecular microparticles and methods of production
07/13/1999CA2135999C Biotherapeutic cell-coated microspheres
07/13/1999CA2131477C Cosmetic or dermatological composition containing an oil-in-water emulsion made of oily globules coated with a stratified liquid crystalline layer
07/13/1999CA2069433C Antiperspirant
07/08/1999WO1999033940A1 Novel polymerizable fatty acids, phospholipids and polymerized liposomes therefrom
07/08/1999WO1999033924A1 Gelatine compositions
07/08/1999WO1999033859A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
07/08/1999WO1999033853A2 Carbohydrates, useful in solid delivery systems
07/08/1999WO1999033846A2 Water soluble prodrugs of secondary and tertiary amine containing drugs and methods of making thereof
07/08/1999WO1999033780A1 Novel polyethoxylated castor oil, process of making the same and formulations thereof
07/08/1999WO1999033558A1 Method for producing an aqueous colloidal dispersion of nanoparticles
07/08/1999WO1999033513A1 Osmotic drug delivery monitoring system and method
07/08/1999WO1999033500A2 Methods, systems, and kits for intravascular nucleic acid delivery
07/08/1999WO1999033493A1 Polyamide oligomers
07/08/1999WO1999033492A1 Method for tissue perfusion
07/08/1999WO1999033491A1 Sustained release medicinal compositions
07/08/1999WO1999033490A1 Sustained release medicinal compositions
07/08/1999WO1999033489A1 Sustained release medicinal compositions
07/08/1999WO1999033486A1 Composition and method for dermal and transdermal administration of a cytokine
07/08/1999WO1999033476A1 Hyperhydrated citicoline, process and use
07/08/1999WO1999033467A1 Method and composition of an oral preparation of itraconazole
07/08/1999WO1999033466A1 Pharmaceutical composition for oral administration
07/08/1999WO1999033464A1 Water-base liquid preparation
07/08/1999WO1999033459A1 Methods of inactivating bacteria including bacterial spores
07/08/1999WO1999033458A1 Medicinal composition for percutaneous administration
07/08/1999WO1999033457A1 Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
07/08/1999WO1999033456A1 Pharmaceutical compositions containing bupropion hydrochloride and an inorganic acid stabilizer
07/08/1999WO1999033455A1 Tetracycline and/or tetracycline derivative(s) for treating, suppressing and preventing of cerebrovascular diseases of nervous system
07/08/1999WO1999033454A2 S-procyclidine for treating urinary incontinence
07/08/1999WO1999033453A2 R-procyclidine for treating urinary incontinence
07/08/1999WO1999033449A1 Beneficial agent delivery system with membrane plug
07/08/1999WO1999033448A1 Tablet for instant and prolonged release of one or more active substances
07/08/1999WO1999033446A1 Osmotic delivery system with membrane plug retention mechanism
07/08/1999WO1999033445A1 Tablet composition
07/08/1999WO1999033352A1 Method of controlling release of antimicrobial agents in chewing gum and gum produced thereby
07/08/1999WO1999033341A1 Substantially water-insoluble matrix containing bioactive substances for slow release
07/08/1999WO1999024073B1 Pharmaceutical compositions containing cyclodextrins and taxoids
07/08/1999WO1999021586A3 Complex between carrageenan and a water soluble drug having a specific granulometry and relative controlled release pharmaceutical compositions
07/08/1999WO1999021533A3 Delivery vehicles for bioactive agents and uses thereof
07/08/1999WO1999020305A8 Veterinary vaccines
07/08/1999WO1999009961A8 Drain system containing additives
07/08/1999WO1999009955A3 Lipid-containing compositions and uses thereof
07/08/1999DE19800294A1 Inductively heatable polymer encapsulated magnetic particles for coupling bio-ligands
07/08/1999DE19800277A1 Verfahren zur Rückgewinnung von Arzneistoffen aus Zubereitungen, deren Vorprodukten oder Abfällen Process for the recovery of drugs from preparations, their precursors or Waste
07/08/1999DE19800006A1 Pocket handkerchief containing homeopathic or pharmaceutical agents
07/08/1999CA2317698A1 Composition and method for dermal and transdermal administration of a cytokine
07/08/1999CA2317090A1 Tetracycline and/or tetracycline derivative(s) for treating, suppressing and preventing of cerebrovascular diseases of nervous system
07/08/1999CA2317021A1 Tablet composition
07/08/1999CA2316989A1 Hyperhydrated citicoline, process and use
07/08/1999CA2316986A1 Aqueous liquid preparation
07/08/1999CA2316807A1 Novel polymerizable fatty acids, phospholipids and polymerized liposomes therefrom
07/08/1999CA2316275A1 Carbohydrates, useful in solid delivery systems
07/08/1999CA2315853A1 Novel polyethoxylated castor oil, process of making the same and formulations thereof
07/08/1999CA2315843A1 S-procyclidine for treating urinary incontinence
07/08/1999CA2315840A1 R-procyclidine for treating urinary incontinence
07/08/1999CA2315695A1 Polyamide oligomers
07/08/1999CA2315092A1 Method for tissue perfusion
07/07/1999EP0927556A1 Dosage units of steroids with a seal coating for the steroids
07/07/1999EP0927553A2 Microemulsions
07/07/1999EP0927214A1 Polymerizable biodegradable polymers including carbonate or dioxanone linkages
07/07/1999EP0927196A1 Polymers containing polysaccharides such as alginates or modified alginates
07/07/1999EP0927191A2 Anti-inflammatory peptides and uses thereof
07/07/1999EP0927053A1 Fragmented polymeric hydrogels for adhesion prevention and their preparation
07/07/1999EP0927037A1 Chlorofluorocarbon-free mometasone furoate aerosol formulations
07/07/1999EP0927036A1 Transdermal therapeutical approach involving a combination of active substances containing oestriol
07/07/1999EP0927034A1 Method of treating urinary incontinence
07/07/1999EP0927032A1 Buccal, non-polar spray for nitroglycerin
07/07/1999EP0927031A1 Pharmaceutical preparation containing nimesulide for oral administration
07/07/1999EP0927026A1 Pharmaceutical compositions containing amisulpride and their therapeutic applications
07/07/1999EP0927025A1 Liposome encapsulated active agent dry powder composition
07/07/1999EP0927024A2 Device and method for treating ophthalmic diseases
07/07/1999EP0926954A1 Antimicrobial compositions
07/07/1999EP0822809A4 Controlled release formulation for water soluble drugs in which a passageway is formed in situ
07/07/1999EP0720472B1 Method of encapsulation and microcapsules produced thereby
07/07/1999EP0689444B1 Tylosin containing sustained release veterinary compositions
07/07/1999EP0500807B1 Tissue moisturizing composition and method
07/07/1999CN1222192A Antisense inhibitors of vascular endothelial growth factor (VEFG/VPF) expression
07/07/1999CN1222084A Insulin preparations containing carbohydrates
07/07/1999CN1222083A Insulin Preparations containing NaCl
1 ... 2538 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 2549 2550 2551 2552 2553 2554 2555 2556 2557 2558 ... 2991